Concepedia
Statistics
Publications
3
Citations
481
H-Index
Active since
1994
Affiliations
University of San Diego(Current)
University of California San Diego
Mark R. Green is an author at University of San Diego specializing in chemotherapy, medicine, and phase ii investigation.
Publications per year
1994–2014
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 441 citations
Medicine, Oncology, Pharmacology +11
A Feasibility Study of Extended Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase II Trial of Cancer and Leukemia Group B
Gerald H. Clamon, James Herndon, Walter L. Eaton et al. · Cancer Investigation · 1994 · 27 citations
Medicine, Oncology, Radiation Oncology +14
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere
Heloisa P. Soares, Soley Bayraktar, Marcelo Blaya et al. · Cancer Chemotherapy and Pharmacology · 2014 · 13 citations
Medicine, Oncology, Pharmacology +14
1–3 of 3